Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06449508
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-10
First Post:
2024-06-01
Brief Title:
The Effectiveness of Probiotics in Neonatal Jaundice
Sponsor:
Tanta University
Organization:
Tanta University
Study Overview
Official Title:
Role of Probiotics Administered as an Adjuvant Therapy in Pathological Neonatal Unconjugated Hyperbilirubinemia
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hyperbilirubinemia is a prevalent problem in babies that necessitates medical attention Probiotic administration as adjuvant therapy may have a positive impact on the pathological neonatal unconjugated hyperbilirubinemia
Detailed Description:
Neonatal jaundice is a common health care issue that affects approximately 9 of newborns after birth The percent of neonates who acquire jaundice in the first week of their birth is about 60 while the percent of breasted neonates who develop jaundice during the first month of their birth is about 10
Phototherapy is the standard therapy for neonates who develop pathological jaundice as it can alter bilirubin structure and increase its excretion
Probiotics can also be used for the treatment of jaundice The efficacy of probiotics depends on their ability to pass across the GIT and cause colonization in the intestinal lumen Hence it leads to a decrease in the bacterial growth in the small bowel a reduction in the function of the gastrointestinal barrier and a regulation of the immune system of the host
Phototherapy is the standard therapy for neonates who develop pathological jaundice as it can alter bilirubin structure and increase its excretion
Probiotics can also be used for the treatment of jaundice The efficacy of probiotics depends on their ability to pass across the GIT and cause colonization in the intestinal lumen Hence it leads to a decrease in the bacterial growth in the small bowel a reduction in the function of the gastrointestinal barrier and a regulation of the immune system of the host
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None